NCT07486791Recruiting
A Clinical Study on the Effect of Cardiopulmonary Function and Quality of Life in Patients With Acute Coronary Syndrome Complicated by Heart Failure by "Lying-Sitting-Standing" Sequential Baduanjin
Source: ClinicalTrials.gov · Last updated 5 May 2026
Brief summary (registry, in English)
This study investigates the effects of a sequential "lying-sitting-standing" Baduanjin intervention on patients with acute coronary syndrome complicated by heart failure. By evaluating cardiopulmonary function and quality of life through indicators such as echocardiography, NT-proBNP, 6MWT, NYHA classification, and SF-36, we aim to compare its efficacy with conventional treatment. The objective is to provide new insights for early cardiac rehabilitation strategies in patients with acute coronary syndrome complicated by heart failure
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 65 (estimated)
- First submitted
- 9 Mar 2026
- Start date
- Mar 2026
- Primary completion date
- Mar 2027
- Lead sponsor
- Xiling Qi
- Diseases
- Heart failure, Coronary artery disease
- NCT number
- NCT07486791
What you commit to
- Study type: Interventional
- Planned participants: 65
- From Mar 2026 to the primary completion date, Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with persistent heart failure symptoms or NYHA functional class IV despite optimal pharmacological therapy;
- Patients with contraindications to cardiac rehabilitation, such as uncontrolled hypertension, uncontrolled arrhythmias, or hemodynamic instability;
- Patients with untreated structural heart disease, such as heart failure caused by valvular heart disease or congenital heart disease;
- Patients in the acute phase of various diseases, such as severe infection, deep vein thrombosis, or severe hepatic or renal failure;
- Patients with disabilities, bone or joint diseases, or neurological disorders that preclude participation in Baduanjin exercises;
Other
- Patients with a life expectancy of less than one year;
- Patients currently participating in other clinical trials.
Who the study is looking for
- Patients meeting the diagnostic criteria for ACS (including unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction)
- Complicated by heart failure during hospitalization
- Age ≤ 85 years
- Muscle strength ≥ grade 3
- No history of mental illness, conscious and able to cooperate independently with this study
- Voluntarily participate in this study and sign the informed consent form
Age in the registry: - to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Second Hospital of Shanxi Medical Coordinator of this site? Confirm its status | Taiyuan | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.